Skip to main content
RT @bella_mehta: Germany based 74 pt #FMF prospective non-interventional, multicenter observational study on Canakinumab

Bella Mehta bella_mehta

3 years 11 months ago
Germany based 74 pt #FMF prospective non-interventional, multicenter observational study on Canakinumab - RELIANCE Registry 63% in remission in 2 yrs serious adverse drug reactions - 1.56 per 100 patient years @RheumNow #ACR22 abst#0138
RT @uptoTate: @ericdeinmd is moderating a great session, difficult to treat RA at #ACR22 right now! #rheumpix @RheumNow

Dr. Rachel Tate uptoTate

3 years 11 months ago
@ericdeinmd is moderating a great session, difficult to treat RA at #ACR22 right now! #rheumpix @RheumNow https://t.co/R5yg3eme6v
Share your favorite pictures from ACR on Twitter and tag #RheumPix and #ACR22 and we'll re-tweet our favorite ones! http

Dr. John Cush RheumNow

3 years 11 months ago
Share your favorite pictures from ACR on Twitter and tag #RheumPix and #ACR22 and we'll re-tweet our favorite ones! https://t.co/y7VWk3lOXD
RT @RichardPAConway: Culerrier @AKronbichler @TerrierBen et al. AAV induced by anti-thyroid drugs. 45 cases. vs AAV - yo

Richard Conway RichardPAConway

3 years 11 months ago
Culerrier @AKronbichler @TerrierBen et al. AAV induced by anti-thyroid drugs. 45 cases. vs AAV - younger (45 vs 68) More skin (54 vs 25%) Less renal (38 vs 73%) Less severe (BVAS 9 vs 13) Less relapse (HR 0.07). Can rechallenge! @rheumnow #ACR22 Abstr#0436 https://t.co/0i7zj615N6 https://t.co/t7fWCOuUsJ
RT @Janetbirdope: OPAL data is a gem! Large Australian data studying JAKi use in #rheumatoidarthritis N=5900 Switching J

Janet Pope Janetbirdope

3 years 11 months ago
OPAL data is a gem! Large Australian data studying JAKi use in #rheumatoidarthritis N=5900 Switching JAKi~JAKi-common. As in TNFi 1st line Rx had longer retention & better efficacy than 2nd & subsequent. Median 1st advanced Rx - same in all JAKs 34 MOA @RheumNow #ACR22 abst0274 https://t.co/FQU4AKXwe9
RT @RichardPAConway: Dey @DrMiniDey @ElenaNikiUK @docrota @LatikaGupta_ et al. COVID vaccination in IIM+multimorbidity.

Richard Conway RichardPAConway

3 years 11 months ago
Dey @DrMiniDey @ElenaNikiUK @docrota @LatikaGupta_ et al. COVID vaccination in IIM+multimorbidity. Adverse events more common, but still infrequent. Both multimorbidity and active IIM increased risk of AEs. @rheumnow #ACR22 Abstr#0177 https://t.co/HA5NaRrPYL https://t.co/TKtagwa0gG
RT @ericdeinmd: Coming soon on #ACR22:
Stream session 12S119 on @ACRheum and @ACRheumDC advocacy

What is new on the Hil

Eric Dein ericdeinmd

3 years 11 months ago
Coming soon on #ACR22: Stream session 12S119 on @ACRheum and @ACRheumDC advocacy What is new on the Hill? What are ACR priorities How quickly can you send an email supporting rheumatologists (quicker than you think!) @RheumNow @AngusWorthing @BlairSolowM @LennMcD @LouisaZiglar https://t.co/sXSBGbCZyM
RT @RichardPAConway: Froehlich et al. MRI superior to US in GCA. For all GCA sensitivity 73% vs 45%. For supra-aortic GC

Richard Conway RichardPAConway

3 years 11 months ago
Froehlich et al. MRI superior to US in GCA. For all GCA sensitivity 73% vs 45%. For supra-aortic GCA sensitivity 73% vs 59%. Both 100% specificity. @rheumnow #ACR22 Abstr#0493 https://t.co/vf2r0h5zUd https://t.co/mlSCcpy2uK
RT @doctorRBC: Very complex conversation on why opioids are used...
Opioid use in patients with PsA and AS led to higher

Robert B Chao, MD doctorRBC

3 years 11 months ago
Very complex conversation on why opioids are used... Opioid use in patients with PsA and AS led to higher healthcare utilization and higher costs. Opioid users - more co-morbidities, smokers, worse disease activity Opioid users spent more on drug costs Abs#0402 @RheumNow #ACR22 https://t.co/dbUPg5LGLy
RT @RichardPAConway: Rathmann et al. Incidence/Prevalence AAV in Sweden over time. Incidence stable. Prevalence increasi

Richard Conway RichardPAConway

3 years 11 months ago
Rathmann et al. Incidence/Prevalence AAV in Sweden over time. Incidence stable. Prevalence increasing and higher in men. Incidence increases with age and commonest 70-84 years @rheumnow #ACR22 Abstr#0451 https://t.co/yCMOC7dAvq https://t.co/y0tqkaV8zX
RT @Yuz6Yusof: #ACR22 Abstr#2081 What is the nature of breakthrough #COVID infection in #lupus patients in Omicron era?

Md Yuzaiful Md Yusof Yuz6Yusof

3 years 11 months ago
#ACR22 Abstr#2081 What is the nature of breakthrough #COVID infection in #lupus patients in Omicron era? A cohort study in New York showed those receiving booster vac were less likely to develop infection vs receiving 2 vaccine doses. Only 2 hospitalised, no deaths @RheumNow https://t.co/6UaTMN5Dev
RT @RichardPAConway: Rooney et al. Seasonality of GCA in UK and Ireland - DCVAS/TABUL/local hospital combined dataset. 2

Richard Conway RichardPAConway

3 years 11 months ago
Rooney et al. Seasonality of GCA in UK and Ireland - DCVAS/TABUL/local hospital combined dataset. 2 peaks - spring/early summer every year, and a second peak most years in autumn or winter. @rheumnow #ACR22 Abstr#0495 https://t.co/Trz8ou9xGh https://t.co/jcS3Z30nz8
RT @Janetbirdope: Do you see #JAKis causing weight gain? 429 Pts BUT during #COVID19 - 68% gained wt in RA 1.5 Kg mean;

Janet Pope Janetbirdope

3 years 11 months ago
Do you see #JAKis causing weight gain? 429 Pts BUT during #COVID19 - 68% gained wt in RA 1.5 Kg mean; and more in SpA 71% w 2.6 Kg. Was it Rx or COVID related? #ACR22 abst0291 @RheumNow
RT @RichardPAConway: Ruiz et al. bDMARD/tsDMARD use in RA after breast cancer. Low use, 15.5% on bDMARD, 1.5% on tsDMARD

Richard Conway RichardPAConway

3 years 11 months ago
Ruiz et al. bDMARD/tsDMARD use in RA after breast cancer. Low use, 15.5% on bDMARD, 1.5% on tsDMARD. Stable use over last 10 years @rheumnow #ACR22 Abstr#0080 https://t.co/0L6uuVtQQw https://t.co/xBH1bUdeSD
RT @bella_mehta: #disparities study using admin data
- 580 pts with incidence childhood #SLE with LN
- LN codes before S

Bella Mehta bella_mehta

3 years 11 months ago
#disparities study using admin data - 580 pts with incidence childhood #SLE with LN - LN codes before SLE codes - more likely publicly insured, rural area, Hispanic ethnicity, kidney transplant - differential access!! @RADoctor @rheumnow #ACR22 abst#0068 https://t.co/uryCZq94dX
×